1/4
I look forward to an interview and indeed the follow up data but in terms of results, at this stage, #TILS investors really couldn't have asked for more.

Improvement in the lungs was "approximately double" with Foralumab on its own, so not in combination with dexamethasone.

2/
If the follow up data cements this incredibly positive picture, then its yet more evidence of what an incredibly strong treatment Foralumab could go on to be.

Dr Howard Steiner ;

"Nasal administration of Foralumab to modulate the human immune system is a potentially..."

3/
"transformative approach for treating patients with a variety of human infectious diseases with an overreactive immune systems."

So as a "first-in-class" treatment with now a potential Covid treatment tag added to it (which lets be frank, is arguably more important than...

4/
even effective vaccines, in the long term fight against Covid), interest in the acquisition of TILS and/or this product in particular, is surely going to rise, which I believe was the aim of this team from day one.

Great news and well done the TILS team.